Targeting proteases in cardiovascular diseases by mass spectrometry-based proteomics.
Targeting proteases in cardiovascular diseases by mass spectrometry-based proteomics.
复制标题
通过基于质谱的蛋白质组学靶向心血管疾病中的蛋白酶。
DOI:
10.1161/circgenetics.110.957811
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
Hardt,Markus
中科院分区:
文献类型:
--
作者:
Klingler,Diana;Hardt,Markus
Proteases hydrolyze peptide bonds, thereby controlling the function of proteins and peptides on the post-translational level. In the cardiovascular system, proteases play pivotal roles in the regulation of blood pressure, coagulation, and other essential physiological processes. Accordingly, proteases are prime targets for therapeutic interventions and diagnostics. Proteases are part of complex proteolytic networks comprised of enzymes, inhibitors, activators, substrates, and cleavage products. Analyzing these networks on a system-wide level is essential to understanding cardiovascular function and how disregulation can lead to pathological conditions. Mass spectrometry-based quantitative and dynamic proteomics approaches are leading the way to enhance our knowledge of proteolytic networks, such as the renin-angiotensin system. Here, we critically review proteomics tools used in protease biology and provide an overview on how these methods can be used to characterize and validate protease function.Proteases catalyze the hydrolysis of peptide bonds, which results in the cleavage of protein and peptide chains, and thereby lead to an irreversible change of protein structure. The fundamental nature of this process makes proteolysis a powerful post-translational modification that can control protein function and abundance. Digestive proteases in the gastrointestinal tract break down proteins fairly indiscriminately, while peptidases involved in cell signaling catalyze very specific cleavage reactions to regulate the abundances of bioactive peptides. Uncontrolled proteolysis could have disastrous physiological consequences; therefore, a multitude of mechanisms exist to tightly regulate proteolytic processing. One of the more basic regulatory principles is substrate specificity, in which the 3-dimensional structure of the protease determines which substrates are accessible to the active site. Other regulatory mechanisms include the activation of proteases from inactive precursors (ie, zymogens) and the limitation of protease activities to specific pH ranges and compartments (eg, lysosomal proteases). Another regulatory element is the spatial and temporal interplay of proteolytic network components; devoid of all required factors (proteases, substrates, and their respective activators and inhibitors) present, reactions may not occur (Figure 1). The renin-angiotensin system can serve as an example of how a proteolytic network regulates a physiological process: 1